Sonida Senior Living, Inc.
NYSE:SNDA · New York Stock Exchange
+$0.39 today
Vol 0.71M · Avg 0.64M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NYSE:SNDA · Revenue to Net Income
Key Ratios
Analysis
$411.9M of revenue converted into -$99.5M of net income for the selected period. Gross margin is -30.6% and net margin is -23.3%, showing how much revenue survives after costs and taxes. EPS is $-5.83, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $381.1M +25.2% | $304.3M +19.2% | $255.3M +7.1% | $238.4M +1.6% | $234.7M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $411.5M +1143.4% | $33.1M +56.9% | $21.1M -22.9% | $27.4M -33.1% | $40.9M | $725.6M | $804.0M | $882.4M |
| Gross Profit | -$30.4M -111.2% | $271.2M +15.8% | $234.2M +11.0% | $211.1M +8.9% | $193.8M | $8.9B | $7.6B | $6.2B |
| Gross Margin | -8.0% -97.1pp | 89.1% -2.6pp | 91.7% +3.2pp | 88.5% +5.9pp | 82.6% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $39.9M -0.4% | $40.0M +24.2% | $32.2M +6.3% | $30.3M -6.3% | $32.3M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $27.8M -90.3% | $286.1M +14.7% | $249.4M +3.8% | $240.4M +5.7% | $227.5M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $56.8M +28.9% | $44.1M +10.4% | $39.9M +3.7% | $38.4M +1.5% | $37.9M | $374.2M | $1.2B | $631.8M |
| EBITDA | $23.2M -70.2% | $78.0M +41.4% | $55.2M +221.4% | $17.2M -91.5% | $201.3M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 6.1% -19.5pp | 25.6% +4.0pp | 21.6% +14.4pp | 7.2% -78.6pp | 85.8% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$58.2M -292.4% | -$14.8M +2.3% | -$15.2M +48.2% | -$29.3M +12.9% | -$33.7M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -15.3% -10.4pp | -4.9% +1.1pp | -5.9% +6.3pp | -12.3% +2.0pp | -14.3% | 16.6% | 24.1% | 22.0% |
| Interest Income | $2.1M +25.1% | $1.7M +176.5% | $608.0K +158.7% | $235.0K +3816.7% | $6.0K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $38.6M +4.4% | $37.0M +2.4% | $36.1M +9.4% | $33.0M -11.3% | $37.2M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$14.0M -218.4% | $11.8M +308.0% | -$5.7M +77.3% | -$25.0M -115.6% | $159.8M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$72.2M -2273.0% | -$3.0M +85.4% | -$20.9M +61.6% | -$54.3M -143.0% | $126.2M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -18.9% -17.9pp | -1.0% +7.2pp | -8.2% +14.6pp | -22.8% -76.5pp | 53.8% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $330.0K +38.1% | $239.0K -5.5% | $253.0K +194.2% | $86.0K -85.2% | $583.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | -$70.8M -3337.5% | -$2.1M +90.2% | -$21.1M +61.2% | -$54.4M -143.3% | $125.6M | $4.9B | $4.8B | $4.7B |
| Net Margin | -18.6% -17.9pp | -0.7% +7.6pp | -8.3% +14.5pp | -22.8% -76.3pp | 53.5% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$4 -681.5% | -$1 +86.0% | -$4 +58.5% | -$9 -124.2% | $38 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$4 -681.5% | -$1 +86.0% | -$4 +58.5% | -$9 -124.4% | $38 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $18.1M +28.2% | $14.1M +107.9% | $6.8M +6.7% | $6.4M +131.2% | $2.8M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $18.1M +28.2% | $14.1M +107.9% | $6.8M +6.7% | $6.4M +129.3% | $2.8M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
COMPASS Pathways plc
NASDAQ:CMPS
$1.16B
Enhabit, Inc.
EHAB
$706.91M
The Oncology Institute, Inc.
NASDAQ:TOI
$522.91M
AngioDynamics, Inc.
NASDAQ:ANGO
$492.52M
Varex Imaging Corporation
NASDAQ:VREX
$439.94M
Community Health Systems, Inc.
NYSE:CYH
$429.09M
Ocugen, Inc.
NASDAQ:OCGN
$426.57M
Standard BioTools Inc.
NASDAQ:LAB
$311.83M
So-Young International Inc.
NASDAQ:SY
$197.47M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$188.97M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does SNDA generate?
Sonida Senior Living, Inc. (SNDA) reported $381.14M of revenue in fiscal 2025.
Is SNDA profitable?
Sonida Senior Living, Inc. (SNDA) reported -$70,779,000.00 of net income, with a net margin of -18.6%.
Explore More
Continue the stock analysis
Jump to another research area for this company.